Birznieks Gunther 4
4 · Vanda Pharmaceuticals Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
Birznieks Gunther
SVP, Business Development
Transactions
- Award
Common Stock
2023-02-16+32,700→ 222,757 total - Award
Stock Option (Right to Buy)
2023-02-16+77,500→ 77,500 totalExercise: $7.05Exp: 2033-02-15→ Common Stock (77,500 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.